4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001258693-26-000010
CHIEF EXECUTIVE OFFICER sold 24,461 shares at an average $52.50 ($1,284,205)
- CHIEF EXECUTIVE OFFICER acquired 225 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-18 | Option exercise 10b5-1 | +225 | $1.79 | $403 | 497,164 | D: show line 1 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-18 | Sale 10b5-1 | −225 | $52.51 | $11,815 | 496,939 | D: show line 2 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-18 | Sale 10b5-1 | −22,236 | $52.50 | $1,167,390 | 474,703 | D: show line 3 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-18 | Sale 10b5-1 | −1,000 | $52.50 | $52,500 | 135,215 | I: show line 4 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-18 | Sale 10b5-1 | −1,000 | $52.50 | $52,500 | 135,215 | I: show line 5 in the form |
| Open-market sales · 24,461 sh · avg $52.50 · $1,284,205 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-18 | Option exercise · Stock Option (right to buy) 10b5-1 | −225 | 0 | D: show line 6 in the form |
Loading xslF345X06/wk-form4_1781827692.xml…